Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
A new Empyrean X-ray powder diffractometer is part of the investment.
July 1, 2021
By: Tim Wright
Editor-in-Chief, Contract Pharma
Almac Sciences has invested approximately $485,000 in an automated crystallization platform to support solid form screening of polymorphs, salts and crystals in addition to crystallization of amorphous materials. A new Empyrean X-ray powder diffractometer, which allows X-ray powder diffraction analysis of samples, represents an additional $345,000 investment by the company. The ChemSpeed Swing Crystal platform automates many common crystallisation operations, which reduces overall duration for solid form screening projects, accommodates a 24/7 run schedule and allows for rapid screening of a significantly wide variety of crystallisation conditions, including where limited sample quantity is available. The platform has the capability to: • Weigh up to eight different powdered solids from 1mg- 100g, including either amorphous or crystalline material and electrostatic powders; • Handle up to 60 different liquids, including a range of organic solvents, acid and base solutions for volumetric dispensing from 100µL-10mL; • Dispense into glass vials or well-plates suitable for direct analysis by X-ray powder diffraction; • Filter slurries and provide inert atmosphere options for sensitive materials, where required; and • Carry out a diverse range of crystallisation unit operations, including evaporation, slurry, temperature cycling, and antisolvent additions, thereby maximising the chance of nucleation / crystallization of the material. The platform is currently set up to accommodate vials and has been selected due to its ability to be adapted, allowing the ability to facilitate well-plates in future. “We are excited to remain at the forefront of solid form research and development by embracing automation to maximize experimental diversity and sample throughput for tailored work programs to ensure our clients receive a premier service offering,” said Jonathan Loughrey, physical sciences manager, Almac Sciences. Tom Moody, vice president technology development and commercialization, Almac Sciences and Arran Chemical Company, said, “Almac Sciences is a cutting-edge science and technology partner and we are committed to investing in the latest equipment to best serve our clients. With the time and cost saving benefits of automation in mind, we’re delighted to announce this further investment into automating our crystallization capabilities which is modular in design enabling elements to be upgraded in the future for expanded use cases.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !